Cargando…
The loss of health status in rheumatoid arthritis and the effect of biologic therapy: a longitudinal observational study
INTRODUCTION: The long-term course of rheumatoid arthritis (RA) in terms of health status is not well understood, nor is the degree of effectiveness of biologic therapy in the community. We modeled the progression of loss of health status, and measured incremental costs and effectiveness of biologic...
Autores principales: | Wolfe, Frederick, Michaud, Kaleb |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2888182/ https://www.ncbi.nlm.nih.gov/pubmed/20196859 http://dx.doi.org/10.1186/ar2944 |
Ejemplares similares
-
Risk of Serious Infection in Patients With Rheumatoid Arthritis Treated With Biologic Versus Nonbiologic Disease‐Modifying Antirheumatic Drugs
por: Ozen, Gulsen, et al.
Publicado: (2019) -
The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis
por: Hernández Alava, Mónica, et al.
Publicado: (2013) -
The Economic Burden of ACPA-Positive Status Among Patients with Rheumatoid Arthritis
por: Shafrin, Jason, et al.
Publicado: (2018) -
Serious infection risk in rheumatoid arthritis compared with non-inflammatory rheumatic and musculoskeletal diseases: a US national cohort study
por: Mehta, Bella, et al.
Publicado: (2019) -
Safety of abatacept compared with other biologic and conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: data from an observational study
por: Ozen, Gulsen, et al.
Publicado: (2019)